263 related articles for article (PubMed ID: 12958359)
21. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.
Voo KS; Fu T; Wang HY; Tellam J; Heslop HE; Brenner MK; Rooney CM; Wang RF
J Exp Med; 2004 Feb; 199(4):459-70. PubMed ID: 14769850
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus: exploiting the immune system by interfering with defective ribosomal products.
Apcher S; Fahraeus R; Manoury B
Microbes Infect; 2004 Nov; 6(13):1212-8. PubMed ID: 15488741
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen PM; Klein G; Kurilla MG; Masucci MG
Nature; 1995 Jun; 375(6533):685-8. PubMed ID: 7540727
[TBL] [Abstract][Full Text] [Related]
25. Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA.
Lista MJ; Martins RP; Billant O; Contesse MA; Findakly S; Pochard P; Daskalogianni C; Beauvineau C; Guetta C; Jamin C; Teulade-Fichou MP; Fåhraeus R; Voisset C; Blondel M
Nat Commun; 2017 Jul; 8():16043. PubMed ID: 28685753
[TBL] [Abstract][Full Text] [Related]
26. Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells.
Ito Y; Demachi-Okamura A; Ohta R; Akatsuka Y; Nishida K; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
J Gen Virol; 2007 Mar; 88(Pt 3):770-780. PubMed ID: 17325349
[TBL] [Abstract][Full Text] [Related]
27. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing.
Blake N; Lee S; Redchenko I; Thomas W; Steven N; Leese A; Steigerwald-Mullen P; Kurilla MG; Frappier L; Rickinson A
Immunity; 1997 Dec; 7(6):791-802. PubMed ID: 9430224
[TBL] [Abstract][Full Text] [Related]
28. Translation efficiency of EBNA1 encoded by lymphocryptoviruses influences endogenous presentation of CD8+ T cell epitopes.
Tellam J; Rist M; Connolly G; Webb N; Fazou C; Wang F; Khanna R
Eur J Immunol; 2007 Feb; 37(2):328-37. PubMed ID: 17236233
[TBL] [Abstract][Full Text] [Related]
29. mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1.
Apcher S; Komarova A; Daskalogianni C; Yin Y; Malbert-Colas L; Fåhraeus R
J Virol; 2009 Feb; 83(3):1289-98. PubMed ID: 19019958
[TBL] [Abstract][Full Text] [Related]
30. Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.
Destro F; Sforza F; Sicurella M; Marescotti D; Gallerani E; Baldisserotto A; Marastoni M; Gavioli R
Immunology; 2011 May; 133(1):105-14. PubMed ID: 21342184
[TBL] [Abstract][Full Text] [Related]
31. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus.
Lautscham G; Rickinson A; Blake N
Microbes Infect; 2003 Apr; 5(4):291-9. PubMed ID: 12706442
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing.
Jones RJ; Smith LJ; Dawson CW; Haigh T; Blake NW; Young LS
Virology; 2003 Sep; 313(2):663-76. PubMed ID: 12954232
[TBL] [Abstract][Full Text] [Related]
33. Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune system.
Angrand G; Quillévéré A; Loaëc N; Dinh VT; Le Sénéchal R; Chennoufi R; Duchambon P; Keruzoré M; Martins RP; Teulade-Fichou MP; Fåhraeus R; Blondel M
Nucleic Acids Res; 2022 Nov; 50(20):11799-11819. PubMed ID: 36350639
[TBL] [Abstract][Full Text] [Related]
34. Fusion of Epstein-Barr virus nuclear antigen-1-derived glycine-alanine repeat to trans-dominant HIV-1 Gag increases inhibitory activities and survival of transduced cells in vivo.
Hammer D; Wild J; Ludwig C; Asbach B; Notka F; Wagner R
Hum Gene Ther; 2008 Jun; 19(6):622-34. PubMed ID: 18533892
[TBL] [Abstract][Full Text] [Related]
35. The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70.
Wang H; Bu L; Wang C; Zhang Y; Zhou H; Zhang X; Guo W; Long C; Guo D; Sun X
Cell Death Dis; 2018 Jun; 9(7):734. PubMed ID: 29959331
[TBL] [Abstract][Full Text] [Related]
36. cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition.
Sharipo A; Imreh M; Leonchiks A; Brändén C; Masucci MG
FEBS Lett; 2001 Jun; 499(1-2):137-42. PubMed ID: 11418128
[TBL] [Abstract][Full Text] [Related]
37. The Gly-Ala repeat modulates the interaction of Epstein-Barr virus nuclear antigen-1 with cellular chromatin.
Coppotelli G; Mughal N; Masucci MG
Biochem Biophys Res Commun; 2013 Feb; 431(4):706-11. PubMed ID: 23348225
[TBL] [Abstract][Full Text] [Related]
38. Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation.
Smith C; Wakisaka N; Crough T; Peet J; Yoshizaki T; Beagley L; Khanna R
Blood; 2009 Jun; 113(24):6148-52. PubMed ID: 19372256
[TBL] [Abstract][Full Text] [Related]
39. Do peptides control their own birth and death?
Fåhraeus R
Nat Rev Mol Cell Biol; 2005 Mar; 6(3):263-7. PubMed ID: 15738990
[TBL] [Abstract][Full Text] [Related]
40. mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells.
Tellam JT; Zhong J; Lekieffre L; Bhat P; Martinez M; Croft NP; Kaplan W; Tellam RL; Khanna R
PLoS Pathog; 2014 Oct; 10(10):e1004423. PubMed ID: 25299404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
